Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
WITHDRAWN
NCT04219046
PHASE2

Evaluation of Naloxegol in the Prevention of POI After Cystectomy

Sponsor: Institut Paoli-Calmettes

View on ClinicalTrials.gov

Summary

Postoperative ileus (POI) is defined as a transient reduction of bowel motility that prevents effective transit of bowel content and tolerance of oral intake following surgical interventions, especially after radical cystectomy. It remains a major factor associated with postoperative morbidity, length of hospital stay and medical costs. In order to optimize perioperative care for patients undergoing radical cystectomy in a context of an ERAS (Enhanced Recovery After Surgery) program, we will evaluate the effectiveness of systemic pharmacologic opioid antagonist treatment.

Official title: Evaluation of Naloxegol, a Peripherally Acting µ-opioid Receptor Antagonist, in the Prevention of Postoperative Ileus After Cystectomy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

0

Start Date

2032-01

Completion Date

2032-01

Last Updated

2026-10-14

Healthy Volunteers

No

Interventions

DRUG

Naloxégol oxalate

Oral administration once daily

DRUG

Placebo oral tablet

Oral administration once daily